Invention Grant
US07641903B2 Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
有权
抗CD70抗体及其用于治疗和预防癌症和免疫疾病的用途
- Patent Title: Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
- Patent Title (中): 抗CD70抗体及其用于治疗和预防癌症和免疫疾病的用途
-
Application No.: US11735365Application Date: 2007-04-13
-
Publication No.: US07641903B2Publication Date: 2010-01-05
- Inventor: Che-Leung Law , Julie McEarchern , Alan F. Wahl
- Applicant: Che-Leung Law , Julie McEarchern , Alan F. Wahl
- Applicant Address: US WA Bothell
- Assignee: Seattle Genetics, Inc.
- Current Assignee: Seattle Genetics, Inc.
- Current Assignee Address: US WA Bothell
- Agency: Townsend and Townsend and Crew, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Disclosed are CD70 binding agents, such as anti-CD70 antibodies and derivatives, that induce a cytotoxic, cytostatic or immunomodulatory without conjugation to a therapeutic agents as well as pharmaceutical compositions and kits comprising the antibody or derivative. Also disclosed are methods for the treatment and prevention of CD70-expressing cancers and immunological disorders comprising administering the CD70 binding agents to a subject.
Public/Granted literature
- US20070292422A1 ANTI-CD70 ANTIBODY AND ITS USE FOR THE TREATMENT AND PREVENTION OF CANCER AND IMMUNE DISORDERS Public/Granted day:2007-12-20
Information query
